These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19253484)

  • 1. Defining the scope of economic evaluation study and selection of comparators.
    Chaiyakunapruk N
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S16-20. PubMed ID: 19253484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of costs.
    Riewpaiboon A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Integration of economic criteria in the recommendations for clinical practice in cancerology].
    Fervers B; Späth HM; Philip T; Carrère MO
    Bull Cancer; 1998 Mar; 85(3):272-80. PubMed ID: 9752319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of economic evaluation results.
    Chaikledkaew U
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S72-80. PubMed ID: 24964702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for guidelines and the use of economic evidence in decision-making in Thailand: lessons learnt from the development of the national list of essential drugs.
    Wibulpolprasert S;
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S1-3. PubMed ID: 19255984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling time in economic evaluation studies.
    Permsuwan U; Guntawongwan K; Buddhawongsa P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S53-8. PubMed ID: 19255986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rehabilitation of the handicapped caught between content programming and economic justification].
    Heier D
    Rehabilitation (Stuttg); 1984 Nov; 23(4):140-7. PubMed ID: 6240094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.
    Bansback N; Maetzel A; Drummond M; Anis A; Marra C; Conway P; Boers M; Tugwell P; Boonen A
    J Rheumatol; 2007 May; 34(5):1178-83. PubMed ID: 17477483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handling uncertainty of the economic evaluation result: sensitivity analysis.
    Limwattananon S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S59-65. PubMed ID: 19253488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of economic evaluation in hand surgery.
    Thoma A; McKnight L; Knight C
    Hand Clin; 2009 Feb; 25(1):113-23, viii. PubMed ID: 19232921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation of health networks: why and how?].
    Rochaix L
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S256-60. PubMed ID: 19596345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critique and impact analysis of decision modeling assumptions.
    Karnon J; Brennan A; Akehurst R
    Med Decis Making; 2007; 27(4):491-9. PubMed ID: 17761961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The desirability and feasibility of economic studies of drugs post-launch.
    Drummond M; Mason A; Towse A
    Eur J Health Econ; 2006 Mar; 7(1):5-6. PubMed ID: 16470374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.